UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity

Blood, 2005-11, Vol.106 (11), p.2400-2400

2005

Volltextzugriff (PDF)

Real-World Safety and Clinical Response of Flumatinib in the Treatment of Chronic Myeloid Leukemia: A Retrospective Study

Blood, 2023-11, Vol.142 (Supplement 1), p.6378-6378

Chunyan, Chen

2023

Volltextzugriff (PDF)

Aberrant Translation Regulated By METTL1/WDR4-Mediated tRNA N 7-Methylguanosine Modification Drives DLBCL Progression

Blood, 2023-11, Vol.142 (Supplement 1), p.5727-5727

2023

Volltextzugriff (PDF)

Adiponectin Promote TPO Response for Treating ITP By Relating Rab6A-myosin9 Trafficking Vehicle Carrying c-Mpl to Cell Surface

Blood, 2023-11, Vol.142 (Supplement 1), p.5398-5398

2023

Volltextzugriff (PDF)

HDAC1/3-Dependent Moderate Liquid-Liquid Phase Separation of YY1 Promotes METTL3 Expression and AML Cell Proliferation

Blood, 2022-11, Vol.140 (Supplement 1), p.11485-11485

2022

Volltextzugriff (PDF)

NK Cells Suppress Hyperfunction of CTLs Via ATM-Mediated NKG2D/NKG2DLs Activation in Severe Aplastic Anemia

Blood, 2022-11, Vol.140 (Supplement 1), p.2933-2934

2022

Volltextzugriff (PDF)

Profiling Immune Cells in DLBCL Patients with Mass Cytometry By Time-of-Flight (CyTOF)

Blood, 2022-11, Vol.140 (Supplement 1), p.3591-3592

2022

Volltextzugriff (PDF)

The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

Blood, 2022-11, Vol.140 (Supplement 1), p.11434-11434

2022

Volltextzugriff (PDF)

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.5586-5586

2019

Volltextzugriff (PDF)

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.3068-3068

2019

Volltextzugriff (PDF)

Phase Separation Mediates RUNX1- Mutation Leukemic Transformation

Blood, 2023-11, Vol.142 (Supplement 1), p.4122-4122

2023

Volltextzugriff (PDF)

Histone Methyltranferase SETD8 Stimulates Proliferation and Anti-Apoptotic Effect in Acute Myeloid Leukemia through Epigenetically Upregulation of CXCR4

Blood, 2023-11, Vol.142 (Supplement 1), p.2754-2754

2023

Volltextzugriff (PDF)

Cyclin D1-Positive Expression Associated with Prognostic Significance and Clinicopathological Characteristics By Paving the Way for Proliferation in Diffuse Large B-Cell Lymphomas

Blood, 2023-11, Vol.142 (Supplement 1), p.1744-1744

2023

Volltextzugriff (PDF)

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.6197-6197

2023

Volltextzugriff (PDF)

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

Blood, 2020-11, Vol.136 (Supplement 1), p.9-10

2020

Volltextzugriff (PDF)

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Blood, 2022-11, Vol.140 (Supplement 1), p.9761-9762

2022

Volltextzugriff (PDF)

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.12010-12010

2022

Volltextzugriff (PDF)

Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression

Blood, 2022-11, Vol.140 (Supplement 1), p.9937-9938

2022

Volltextzugriff (PDF)

The Publication Trends and Hotspots of Multiple Myeloma Research from 2010 to 2019: A 10-Year Bibliometric Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.12544-12544

2022

Volltextzugriff (PDF)

Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China

Blood, 2023-11, Vol.142 (Supplement 1), p.6552-6552

2023

Volltextzugriff (PDF)

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

Blood, 2008-09, Vol.112 (5), p.2101-2110

2008

Volltextzugriff (PDF)

The Role of TLR4 Inducing Macrophage Pyroptosis in the Pathogenesis of Severe Aplastic Anemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1114-1114

2021

Volltextzugriff (PDF)

Serum Level of IFN-a2 and Regulatory T-Cell Subsets Correlates with Disease Progression in De Novo Myelodysplastic Syndrome

Blood, 2021-11, Vol.138 (Supplement 1), p.3671-3671

2021

Volltextzugriff (PDF)

Pyruvate Kinase M2 Regulates Hif-1alpha Activity in Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1109-1109

2021

Volltextzugriff (PDF)

Developing CD70-Targeted CAR-T Cells for the Treatment of Hematological and Solid Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.12695-12695

2022

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Aktive Filter

SprachePolnisch

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(124)

Sprache

Englisch
(124)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity

Real-World Safety and Clinical Response of Flumatinib in the Treatment of Chronic Myeloid Leukemia: A Retrospective Study

Aberrant Translation Regulated By METTL1/WDR4-Mediated tRNA N 7-Methylguanosine Modification Drives DLBCL Progression

Adiponectin Promote TPO Response for Treating ITP By Relating Rab6A-myosin9 Trafficking Vehicle Carrying c-Mpl to Cell Surface

HDAC1/3-Dependent Moderate Liquid-Liquid Phase Separation of YY1 Promotes METTL3 Expression and AML Cell Proliferation

NK Cells Suppress Hyperfunction of CTLs Via ATM-Mediated NKG2D/NKG2DLs Activation in Severe Aplastic Anemia

Profiling Immune Cells in DLBCL Patients with Mass Cytometry By Time-of-Flight (CyTOF)

The Expression of SREBF1 Inducing By Dexamethasone Promotes Bone Marrow Mesenchymal Stromal Cells Differentiate to Adipocytes to Attract and Protect the Residual T-Cell Acute Lymphoblastic Leukemia Cells

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

Phase Separation Mediates RUNX1- Mutation Leukemic Transformation

Histone Methyltranferase SETD8 Stimulates Proliferation and Anti-Apoptotic Effect in Acute Myeloid Leukemia through Epigenetically Upregulation of CXCR4

Cyclin D1-Positive Expression Associated with Prognostic Significance and Clinicopathological Characteristics By Paving the Way for Proliferation in Diffuse Large B-Cell Lymphomas

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial

Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression

The Publication Trends and Hotspots of Multiple Myeloma Research from 2010 to 2019: A 10-Year Bibliometric Analysis

Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

The Role of TLR4 Inducing Macrophage Pyroptosis in the Pathogenesis of Severe Aplastic Anemia

Serum Level of IFN-a2 and Regulatory T-Cell Subsets Correlates with Disease Progression in De Novo Myelodysplastic Syndrome

Pyruvate Kinase M2 Regulates Hif-1alpha Activity in Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

Developing CD70-Targeted CAR-T Cells for the Treatment of Hematological and Solid Malignancies

Aktive Filter

Suchergebnisse filtern